In the mouse-model experiment, a reduced number of liver Treg cells was demonstrated in mice with MASLD (32), and decreased expression of Foxp3 mRNA was observed in mice with advanced MASLD (15). Here, FOXP3 is linked to metabolic dysfunction-associated steatotic liver disease.